• Fields of application

  • Focus on

  • Content type

  • Showcase

  • Regional News

Koen Dewaele (CEO) started ADx about three and a half years ago, when Fujirebio (the former Innogenetics), cut back its research activities drastically. Four employees who already worked on Alzheimer’s biomarkers decided to continue the research and founded their own company. The company develops diagnostic tests to screen for Alzheimer’s.
  • Fields of application

  • Focus on

  • Content type

  • Showcase

  • Regional News

Koen Dewaele (CEO) started ADx about three and a half years ago, when Fujirebio (the former Innogenetics), cut back its research activities drastically. Four employees who already worked on Alzheimer’s biomarkers decided to continue the research and founded their own company. The company develops diagnostic tests to screen for Alzheimer’s.